HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: ard.2003.020313v1 63/8/931    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pincus, T Articles by Fort, J G Search for Related Content PubMed PubMed Citation Articles by Pincus, T Articles by Fort, J G

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis

¹ Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
² Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
³ Pfizer Corporation, USA
⁴ Department of Medicine, Jyvaskyla Central Hospital, Jyvaskyla, Finland
⁵ Division of Rheumatology, Case-Western University, Cleveland, OH 44106, USA
⁶ Wichita Arthritis Center, University of Kansas School of Medicine, 1035 North Emporia, Suite 230, Wichita, KS 67214, USA
⁷ Hospital for Special Surgery – Weill Medical College of Cornell University, New York, NY, USA
⁸ Department of Medicine, Harvard University, Boston, MA 02115, USA

Correspondence to:
Correspondence to:
Professor T Pincus
Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, 203 Oxford House, Box 5, Nashville, TN 37232–4500, USA; t.pincus{at}vanderbilt.edu

Background: Acetaminophen (paracetamol) is recommended as the initial pharmacological treatment for knee or hip osteoarthritis. However, survey and clinical trial data indicate greater efficacy for non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 specific inhibitors.

Design: Two randomised, double blind, placebo controlled, crossover multicentre clinical trials, Patient Preference for Placebo, Acetaminophen or Celecoxib Efficacy Studies (PACES).

Patients: Osteoarthritis of knee or hip.

Intervention: "Wash out" of treatment; randomisation; 6 weeks of celecoxib 200 mg/day, acetaminophen 1000 mg four times a day, or placebo; second "wash out;" crossover to 6 weeks of second treatment.

Measurements: Western Ontario McMaster Osteoarthritis Index (WOMAC), visual analogue pain scale, patient preference between two treatments.

Results: Celecoxib was more efficacious than acetaminophen in both periods in both studies; WOMAC and pain scale scores differed at p<0.05 in period II and both periods combined of PACES-a and in periods I and II and both periods combined in PACES-b, but not in period I of PACES-a. Acetaminophen was more efficacious than placebo, generally p<0.05 in PACES-b, and >0.05 in PACES-a. Patient preferences were 53% celecoxib v 24% acetaminophen in PACES-a (p<0.001) and 50% v 32% in PACES-b (p = 0.009); 37% acetaminophen v 28% placebo in PACES-a (p = 0.340) and 48% v 24% in PACES-b (p = 0.007). No clinically or statistically significant differences were seen in adverse events or tolerability among the three treatment groups.

Conclusions: Greater efficacy was seen for celecoxib v acetaminophen v placebo, while adverse events and tolerability were similar. Variation in results and statistical significance in the two different trials are of interest.

Abbreviations: MDHAQ, Multidimensional Health Assessment Questionnaire; NSAIDs, non-steroidal anti-inflammatory drugs; SF-36, Short Form-36; WOMAC, Western Ontario McMaster Osteoarthritis Index

Keywords: celecoxib; osteoarthritis; acetaminophen; placebo; WOMAC; pain visual analogue scale; paracetamol

This article has been cited by other articles:

				P A Scott, G H Kingsley, C M Smith, E H Choy, and D L Scott Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials Ann Rheum Dis, October 1, 2007; 66(10): 1296 - 1304. [Abstract] [Full Text] [PDF]

				E. Rahme and H. Nedjar Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study Rheumatology, March 1, 2007; 46(3): 435 - 438. [Abstract] [Full Text] [PDF]

				F P Luyten, P Geusens, M Malaise, L De Clerck, R Westhovens, F Raeman, D Vander Mijnsbrugge, L Mathy, J P Hauzeur, F De Keyser, et al. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip Ann Rheum Dis, January 1, 2007; 66(1): 99 - 106. [Abstract] [Full Text] [PDF]

				Y Yazici and H Yazici A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor {alpha} inhibitors Ann Rheum Dis, January 1, 2007; 66(1): 124 - 127. [Abstract] [Full Text] [PDF]

				M. J. Yelland, C. J. Nikles, N. McNairn, C. B. Del Mar, P. J. Schluter, and R. M. Brown Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials Rheumatology, January 1, 2007; 46(1): 135 - 140. [Abstract] [Full Text] [PDF]

				R. Lehman Evidently... Evid. Based Med., February 1, 2005; 10(1): 8 - 8. [Full Text] [PDF]

				Other articles noted Evid. Based Med., February 1, 2005; 10(1): 31 - 32. [Full Text] [PDF]

				L Denoeud, B Mazieres, C Payen-Champenois, and P Ravaud First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence Ann Rheum Dis, January 1, 2005; 64(1): 70 - 74. [Abstract] [Full Text] [PDF]

				E Roddy, W Zhang, M Doherty, and M. Dougados Home based exercise for osteoarthritis * Author's reply Ann Rheum Dis, January 1, 2005; 64(1): 170 - 171. [Full Text] [PDF]

				R Neame, W Zhang, and M Doherty A historic issue of the Annals: three papers examine paracetamol in osteoarthritis Ann Rheum Dis, August 1, 2004; 63(8): 897 - 900. [Full Text] [PDF]

				C Miceli-Richard, M Le Bars, N Schmidely, and M Dougados Paracetamol in osteoarthritis of the knee Ann Rheum Dis, August 1, 2004; 63(8): 923 - 930. [Abstract] [Full Text] [PDF]